148 related articles for article (PubMed ID: 6311308)
1. Immunodepression of lymphocyte response in mouse hepatitis virus 3 infection.
Krzystyniak K; Dupuy JM
Biomed Pharmacother; 1983; 37(2):68-74. PubMed ID: 6311308
[TBL] [Abstract][Full Text] [Related]
2. Mouse hepatitis virus 3 pathogenicity expressed by a lytic viral infection in bone marrow 14.8+ mu+ B lymphocyte subpopulations.
Jolicoeur P; Lamontagne L
J Immunol; 1989 Dec; 143(11):3722-30. PubMed ID: 2555417
[TBL] [Abstract][Full Text] [Related]
3. Mouse hepatitis virus 3 replication in T and B lymphocytes correlate with viral pathogenicity.
Lamontagne L; Descoteaux JP; Jolicoeur P
J Immunol; 1989 Jun; 142(12):4458-65. PubMed ID: 2542412
[TBL] [Abstract][Full Text] [Related]
4. Resistance of genetically selected mice to MHV3 infection is not dependent on the H2O2 release by macrophages.
Vassão R; Russo M; Marcondes MC; Pereira CA
Microb Pathog; 1993 Mar; 14(3):169-76. PubMed ID: 8391622
[TBL] [Abstract][Full Text] [Related]
5. Altered splenic T cell function of BALB/cByJ mice infected with mouse hepatitis virus or Sendai virus.
Smith AL; Bottomly K; Winograd DF
J Immunol; 1987 May; 138(10):3426-30. PubMed ID: 2437194
[TBL] [Abstract][Full Text] [Related]
6. TNF alpha, IL-1 and O2- release by macrophages do not correlate with the anti-mouse hepatitis virus 3 effect induced by interferon gamma.
Lucchiari MA; Modolell M; Vassão RC; Pereira CA
Microb Pathog; 1993 Dec; 15(6):447-54. PubMed ID: 8007817
[TBL] [Abstract][Full Text] [Related]
7. Impaired T and B cell subpopulations involved in a chronic disease induced by mouse hepatitis virus type 3.
Jolicoeur P; Lamontagne L
J Immunol; 1994 Aug; 153(3):1318-7. PubMed ID: 8027559
[TBL] [Abstract][Full Text] [Related]
8. Mouse hepatitis virus infection suppresses modulation of mouse spleen T-cell activation.
Cook-Mills JM; Munshi HG; Perlman RL; Chambers DA
Immunology; 1992 Mar; 75(3):542-5. PubMed ID: 1572700
[TBL] [Abstract][Full Text] [Related]
9. [Response of splenic lymphocytes to phytohemagglutinin and bacterial lipopolysaccharide in mice, sensitive and resistant to mouse hepatitis virus 3 (MHV3)].
Grollemund E; Obert G; Nonnenmacher H; Kirn A
C R Seances Acad Sci III; 1981 Feb; 292(8):533-6. PubMed ID: 6261984
[TBL] [Abstract][Full Text] [Related]
10. Virus-pesticide interactions with murine cellular immunity after sublethal exposure to dieldrin and aminocarb.
Fournier M; Chevalier G; Nadeau D; Trottier B; Krzystyniak K
J Toxicol Environ Health; 1988; 25(1):103-18. PubMed ID: 3418741
[TBL] [Abstract][Full Text] [Related]
11. Cellular and metabolic requirements for induction of macrophage procoagulant activity by murine hepatitis virus strain 3 in vitro.
Chung S; Sinclair S; Leibowitz J; Skamene E; Fung LS; Levy G
J Immunol; 1991 Jan; 146(1):271-8. PubMed ID: 1701794
[TBL] [Abstract][Full Text] [Related]
12. Murine hepatitis caused by lymphocytic choriomeningitis virus. II. Cells involved in pathogenesis.
Gossmann J; Lohler J; Utermohlen O; Lehmann-Grube F
Lab Invest; 1995 May; 72(5):559-70. PubMed ID: 7745950
[TBL] [Abstract][Full Text] [Related]
13. Role of virus-specific CD4+ cytotoxic T cells in recovery from mouse hepatitis virus infection.
Wijburg OL; Heemskerk MH; Sanders A; Boog CJ; Van Rooijen N
Immunology; 1996 Jan; 87(1):34-41. PubMed ID: 8666433
[TBL] [Abstract][Full Text] [Related]
14. T lymphocyte-dependent difference in susceptibility between DDD and C3H mice to mouse hepatitis virus, MHV-3.
Yamada A; Taguchi F; Fujiwara K
Jpn J Exp Med; 1979 Dec; 49(6):413-21. PubMed ID: 232196
[TBL] [Abstract][Full Text] [Related]
15. In vitro and long-term in vivo immune dysfunction after infection of BALB/c mice with mouse hepatitis virus strain A59.
Cray C; Mateo MO; Altman NH
Lab Anim Sci; 1993 Apr; 43(2):169-74. PubMed ID: 8100597
[TBL] [Abstract][Full Text] [Related]
16. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
Pope M; Chung SW; Mosmann T; Leibowitz JL; Gorczynski RM; Levy GA
J Immunol; 1996 May; 156(9):3342-9. PubMed ID: 8617959
[TBL] [Abstract][Full Text] [Related]
17. Delayed-type hypersensitivity in mouse hepatitis virus infection in mice.
Kyuwa S; Fujiwara K
Jpn J Exp Med; 1984 Apr; 54(2):81-6. PubMed ID: 6088859
[TBL] [Abstract][Full Text] [Related]
18. Induction of natural killer cells and interferon during mouse hepatitis virus infection of resistant and susceptible inbred mouse strains.
Pereira CA; Mercier G; Oth D; Dupuy JM
Immunobiology; 1984 Jan; 166(1):35-44. PubMed ID: 6201433
[TBL] [Abstract][Full Text] [Related]
19. In vitro activation of woodchuck lymphocytes measured by radiopurine incorporation and interleukin-2 production: implications for modeling immunity and therapy in hepatitis B virus infection.
Cote PJ; Gerin JL
Hepatology; 1995 Sep; 22(3):687-99. PubMed ID: 7544755
[TBL] [Abstract][Full Text] [Related]
20. Experimental murine hepatitis and inducible suppressor cell function.
Hodgson HJ; Wands JR; Isselbacher KJ
J Clin Lab Immunol; 1982 Jan; 7(1):45-9. PubMed ID: 6279850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
